Ascentage Pharma Group International (AAPG) Stock Forecast & Price Target
Ascentage Pharma Group International · NASDAQ
$17.43-0.65 (-3.57%)
15-min delayed · Jul 31, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 5 firms covering Ascentage Pharma Group International, 5 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. Targets are tightly clustered, $45.00 to $51.00, so the covering firms are broadly aligned. The average target of $47.40 sits 172% above the current $17.43. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 4 to 5 over recent months. On the fundamentals, the Street sees revenue growth near 51% this year and 71% next, consensus EPS building from about $-0.50 next quarter toward $-1.19 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS5 ratings
Strong Buy
Strong Buy00%
Buy5100%
Hold00%
Sell00%
Strong Sell00%
Based on 5 analysts giving stock ratings to Ascentage Pharma Group International.
As of Aug, 5 of 5 firms rate AAPG a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
AAPG EPS & revenue forecast
EPS · NEXT QUARTER
$-0.50
Range $-0.50 – $-0.50 · 1 analysts
Next period, 1 analysts expect Ascentage Pharma Group International to earn $-0.50 a share (range $-0.50 – $-0.50), versus — a year earlier. Full-year consensus is $-1.52, growing to $-1.19 the year after.
REVENUE · NEXT QUARTER
—
Range — – — · 1 analysts
Revenue is expected to reach — (range — – —). Full-year consensus is $861.1M, rising to $1.5B next year.
Top analysts covering Ascentage Pharma Group International
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on AAPG.
#1
Mayank Mamtani
B. Riley Securities · Rank #9
Buy
$45.00+158.2% to target
Overall win rate
53%
+ Follow
#2
JM
Jeet Mukherjee
BTIG
Buy
$48.00+175.5% to target
Coverage
—
+ Follow
#3
GR
Gregory Renza
Truist Securities
Buy
$51.00+192.7% to target
Coverage
—
+ Follow
#4
Brian Cheng
JP Morgan
Buy
$46.00+164.0% to target
Coverage
—
+ Follow
#5
Matthew Biegler
Oppenheimer
Buy
$45.00+158.2% to target
Coverage
—
+ Follow
AAPG stock forecast FAQ
What is AAPG's average 12-month price target?+
The 5 analysts with a live target average $47.40 for Ascentage Pharma Group International over the next 12 months, ranging from a $51.00 high to a $45.00 low.
Is AAPG stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 5 analyst ratings, 5 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for AAPG?+
The Street-high target is $51.00 (Truist Securities), and the Street-low is $45.00 (B. Riley Securities). The average of all 5 active targets is $47.40.
How many Wall Street analysts cover AAPG?+
5 analysts have an active rating on Ascentage Pharma Group International, and 5 firms carry a live 12-month price target.
Who is the most accurate analyst covering AAPG?+
Among analysts who currently cover AAPG, Mayank Mamtani of B. Riley Securities has the strongest overall Quantellect track record (Rank #9). Their current call is Buy with a $45.00 target.
What is Ascentage Pharma Group International's projected EPS for next quarter?+
The consensus estimate is $-0.50 per share (range $-0.50 – $-0.50) across 1 analysts. Full-year EPS is projected at $-1.52, rising to $-1.19 the following year.
How much revenue is Ascentage Pharma Group International expected to report next quarter?+
Consensus revenue is — (range — – —). Full-year revenue is projected at $861.1M, growing to $1.5B next year.
Have analysts been upgrading or downgrading AAPG lately?+
As of Aug, 5 of 5 firms rate AAPG a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their AAPG calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
